Fundamental Analysis of LATECOERE(EPA:LAT) stock

Fundamental Rating

Overall LAT gets a fundamental rating of 2 out of 10. We evaluated LAT against 38 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LAT have multiple concerns. While showing a medium growth rate, LAT is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

LAT had negative earnings in the past year.

In the past year LAT has reported a negative cash flow from operations.

LAT had negative earnings in 4 of the past 5 years.

LAT had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -17.69%, LAT is not doing good in the industry: 91.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-17.69%
ROE	N/A
ROIC	N/A

ROA(3y)-23.52%

ROA(5y)-14.95%

ROE(3y)-396.82%

ROE(5y)-240.93%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LAT has a Gross Margin of 36.63%. This is in the better half of the industry: LAT outperforms 61.11% of its industry peers.

LAT's Gross Margin has been stable in the last couple of years.

LAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.63%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.07%

GM growth 5Y-0.89%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LAT does not have a ROIC to compare to the WACC, probably because it is not profitable.

LAT has more shares outstanding than it did 1 year ago.

LAT has more shares outstanding than it did 5 years ago.

LAT has a worse debt/assets ratio than last year.

2.2 Solvency

LAT has an Altman-Z score of -0.42. This is a bad value and indicates that LAT is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -0.42, LAT is not doing good in the industry: 88.89% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-0.42

ROIC/WACCN/A

WACC3.71%

2.3 Liquidity

LAT has a Current Ratio of 0.99. This is a bad value and indicates that LAT is not financially healthy enough and could expect problems in meeting its short term obligations.

LAT has a Current ratio of 0.99. This is in the lower half of the industry: LAT underperforms 75.00% of its industry peers.

A Quick Ratio of 0.47 indicates that LAT may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.47, LAT is doing worse than 80.56% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.99
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.96%, which is quite impressive.

The Revenue has grown by 41.00% in the past year. This is a very strong growth!

Measured over the past years, LAT shows a decrease in Revenue. The Revenue has been decreasing by -6.56% on average per year.

EPS 1Y (TTM)39.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%77.95%

Revenue 1Y (TTM)41%

Revenue growth 3Y-13.08%

Revenue growth 5Y-6.56%

Sales Q2Q%43.01%

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth

Based on estimates for the next years, LAT will show a quite strong growth in Revenue. The Revenue will grow by 17.87% on average per year.

EPS Next Y38.99%

EPS Next 2Y41.42%

EPS Next 3Y25.99%

EPS Next 5YN/A

Revenue Next Year29.67%

Revenue Next 2Y22.51%

Revenue Next 3Y17.87%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LAT is valued more expensive than 80.56% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	41.98

4.3 Compensation for Growth

LAT's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3Y25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LAT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LATECOERE

EPA:LAT (10/30/2024, 7:00:00 PM)

0.0069

0 (-1.43%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap86.01M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.69%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	36.63%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.65

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.99
Quick Ratio	0.47
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)39.96%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y38.99%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)41%

Revenue growth 3Y-13.08%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

LATECOERE (LAT.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens